文献速递瓣膜外科

50岁以下成人生物瓣与机械瓣主动脉瓣置换比较

Bioprosthetic aortic valve replacement: Revisiting prosthesis choice in patients younger than 50 years old.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-09-13

该回顾性分析纳入1997至2006年加州和纽约州5111例18-50岁首次主动脉瓣置换患者,中位随访11.8年。倾向评分匹配1175对后,生物瓣与机械瓣15年生存率无显著差异,生物瓣卒中与出血率更低但再手术率更高,提示生物瓣是合理替代选择。

要点

  • 18-50岁患者生物瓣与机械瓣15年生存率无显著差异。
  • 生物瓣卒中与出血风险更低,但再手术率显著更高。
  • 年龄与瓣膜选择对生存无交互作用。

核心结论

  • 在18-50岁成人主动脉瓣置换中,生物瓣是机械瓣的合理替代选择。

研究设计与样本

  • 回顾性分析1997至2006年加州和纽约州5111例18-50岁首次主动脉瓣置换患者,中位随访11.8年,倾向评分匹配1175对。

主要发现

  • 生物瓣15年卒中率5.4%(95%CI 3.8%-7.2%),机械瓣8.1%(95%CI 6.3%-10.2%),HR 0.62(95%CI 0.43-0.91)。
  • 生物瓣15年出血率4.2%(95%CI 3.0%-5.6%),机械瓣8.4%(95%CI 6.6%-10.4%),HR 0.48(95%CI 0.33-0.69)。
  • 生物瓣15年再手术率24.5%(95%CI 21.3%-27.8%),机械瓣9.3%(95%CI 7.2%-11.7%),HR 5.9(95%CI 3.2-11.0)。

临床怎么用

  • 对于18-50岁主动脉瓣置换患者,生物瓣可作为机械瓣的合理替代,需权衡较低卒中出血风险与较高再手术风险。

局限性

  • 终身风险代表性不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aortic prosthesis choice is controversial in young adults because robust comparative outcome data are lacking. We therefore compared mortality and morbidity in young adults after bioprosthetic versus mechanical aortic valve replacement. METHODS: This was a retrospective analysis of 5111 patients aged 18 to 50 years undergoing primary aortic valve replacement in California and New York State from 1997 to 2006. Median follow-up time was 11.8 years (maximum 18.9 years). The primary endpoint was mortality; secondary endpoints were stroke, bleeding, and reoperation. Propensity score matching yielded 1175 patient pairs. RESULTS: Bioprosthetic valves increased from 14% to 47% of aortic valve replacements between 1997 and 2014 (P < .001). There was no survival difference with bioprosthetic versus mechanical aortic valves in the propensity score-matched cohort: actuarial 15-year survival was 79.0% (95% confidence interval [CI], 75.8%-81.8%) versus 81.5% (95% CI, 78.5%-84.2%) respectively (hazard ratio [HR], 1.14; 95% CI, 0.93-1.40, P = .20). No interaction was found between age and prosthesis choice on survival (Pinteraction = 0.16). After bioprosthetic valve replacement, stroke rates were lower (5.4% [95% CI, 3.8%-7.2%] vs 8.1% [95% CI, 6.3%-10.2%], HR 0.62 [95% CI 0.43-0.91]), bleeding rates were lower (4.2% [95% CI, 3.0-5.6%] vs 8.4% [95% CI, 6.6-10.4%], HR 0.48 [95% CI, 0.33-0.69]), but reoperation rates were greater (24.5% [95% CI, 21.3%-27.8%] vs 9.3% [95% CI, 7.2%-11.7%], HR 5.9 [95% CI 3.2-11.0]) at 15 years versus mechanical valve replacement. CONCLUSIONS: Although lifetime risks are represented incompletely, these findings suggest that in adults aged 18-50 years, bioprostheses are a reasonable alternative to mechanical valves for aortic valve replacement.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Schnittman SR, Adams DH, Itagaki S, et al. Bioprosthetic aortic valve replacement: Revisiting prosthesis choice in patients younger than 50 years old. J Thorac Cardiovasc Surg. 2017. PMID: 29110948. doi:10.1016/j.jtcvs.2017.08.121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。